ABBV-744
Pwodwi detay
Tags pwodwi
| Gwosè pake | Disponibilite | Pri (USD) |
| 100 mg | Nan Aksyon | 300 |
| 500 mg | Nan Aksyon | 850 |
| 1g | Nan Aksyon | 1250 |
| Plis gwosè | Jwenn Quotes | jwenn Quotes |
Non Chimik:
N-etil-4-(2-(4-fluoro-2,6-dimethylphenoxy)-5-(2-hydroxypropan-2-yl)phenyl)-6-methyl-7-oxo-6,7-dihydro-1H -pyrrolo [2,3-c] piridin-2-carboxamide
Kòd SMILES:
O=C(C(N1)=CC(C(C2=CC(C(C)(O)C)=CC=C2OC3=C(C)C=C(F)C=C3C)=CN4C)=C1C4 =O)NCC
Kòd InChi:
InChI=1S/C28H30FN3O4/c1-7-30-26(33)22-13-20-21(14-32(6)27(34)24(20)31-22)19-12-17(28(28) 4,5)35)8-9-23(19)36-25-15(2)10-18(29)11-16(25)3/h8-14,31,35H,7H2,1-6H3, (H,30,33)
InChi kle:
OEDSFMUSNZDJFD-UHFFFAOYSA-N
Mot:
ABBV-744, ABBV 744, ABBV744, 2138861-99-9
Solibilite:Soluble nan DMSO
Depo:0 - 4 ° C pou kout tèm (jou a semèn), oswa -20 ° C pou tèm long (mwa).
Deskripsyon:
ABBV-744 se yon inibitè bromodomen BET selektif BDII ke yo ap envestige pou trete AML ak kansè pwostat ki reziste kastrasyon metastik.
Sib: BET bromodomain